Wilson Mark Andrew

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)2%2%0%0%
Sale Success Rate1 of 72 of 71 of 70 of 70 of 7

Nektar Therapeutics

Drugs » Drug Delivery

Chief Legal Officer:

Holdings: 218.86K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--